SNPHF(SNPHF)
SNPHF
No analyst ratings available
No analyst price targets available for SNPHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $313.67B | $324.22B | $337.27B | $360.97B | $370.94B |
| Low | $302.05B | $302.97B | $319.89B | $342.37B | $351.82B |
| High | $322.97B | $346.56B | $354.00B | $378.88B | $389.34B |
| EBITDA Avg | $68.98B | $74.00B | $80.49B | $90.76B | $96.54B |
| Low | $65.77B | $70.46B | $76.55B | $86.16B | $91.60B |
| High | $72.07B | $77.40B | $84.29B | $95.18B | $101.30B |
| EBIT Avg | $50.39B | $55.18B | $61.34B | $71.05B | $76.27B |
| Low | $47.18B | $51.65B | $57.40B | $66.46B | $71.33B |
| High | $53.48B | $58.58B | $65.14B | $75.47B | $81.03B |
| Net Income Avg | $40.33B | $44.36B | $49.55B | $57.71B | $62.11B |
| Low | $37.63B | $41.39B | $46.23B | $53.85B | $57.95B |
| High | $42.93B | $47.22B | $52.74B | $61.44B | $66.11B |
| EPS Avg | $122.82 | $135.10 | $150.88 | $175.76 | $189.14 |
| Low | $114.59 | $126.05 | $140.77 | $163.98 | $176.46 |
| High | $130.74 | $143.81 | $160.61 | $187.09 | $201.33 |
| Analysts (Rev / EPS) | 9 / 1 | 9 / 1 | 4 / 1 | 4 / 1 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $75.21B | $80.19B | $86.85B | $80.06B |
| Low | $73.84B | $77.75B | $84.71B | $78.09B |
| High | $75.92B | $81.74B | $88.11B | $81.22B |
| EBITDA Avg | $16.23B | $18.40B | $20.62B | $15.70B |
| Low | $15.88B | $17.97B | $20.13B | $15.37B |
| High | $16.44B | $18.65B | $20.91B | $15.90B |
| EBIT Avg | $11.55B | $13.71B | $15.90B | $10.98B |
| Low | $11.20B | $13.29B | $15.41B | $10.64B |
| High | $11.76B | $13.96B | $16.20B | $11.18B |
| Net Income Avg | $9.28B | $11.09B | $12.94B | $8.80B |
| Low | $8.99B | $10.74B | $12.53B | $8.52B |
| High | $9.46B | $11.31B | $13.19B | $8.96B |
| EPS Avg | $28.77 | $34.39 | $40.12 | $27.27 |
| Low | $27.86 | $33.29 | $38.84 | $26.40 |
| High | $29.32 | $35.04 | $40.88 | $27.79 |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 | 1 / 1 | 1 / 1 |